SEEL

Seelos Therapeutics, Inc. Common Stock
SEEL

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

SEEL was delisted on the 15th of October, 2024.

Back to rankings

2 hedge funds and large institutions have $4.2M invested in Seelos Therapeutics, Inc. Common Stock in 2017 Q1 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more funds holding in top 10

Funds holding in top 10: →

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
2
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$480K

Top Sellers

1
-$263K
2
-$41K
3
-$34K
4
Geode Capital Management
Geode Capital Management
Massachusetts
-$33K
5
AIM
Acrospire Investment Management
Illinois
-$21K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$3.06M
2
$720K
3
$107K
4
$67K
5
$54K
6
$54K
7
$38K
8
$27K
9
$22K
10
$19K
11
$9K
12
$6K
13
$6K
14
$6K
15
$3K
16
$2K
17
$1.48K
18
$1K
19
$1K
20
$1K
21
$1K
22
$1K
23
–
24
–
25
–
1
2